Board Changes

Summary by AI BETAClose X

Standard Life plc announced that Siobhan Boylan, the Group Shareholder Nominated Non-Executive Director nominated by Aberdeen Group plc, will be leaving the Board effective October 12, 2026. This departure follows Aberdeen's sale of 52,000,000 ordinary shares in Standard Life, reducing their holding to approximately 5.3%. Consequently, Aberdeen no longer meets the required ownership threshold to nominate a director to the Board, as per their arrangements with Standard Life.

Disclaimer*

Standard Life plc
12 October 2026
 

LEI: 2138001P49OLAEU33T68

 

12 October 2026

 

Standard Life plc - Board Changes

 

The Board of Standard Life plc ('Standard Life') announces that Siobhan Boylan, the Group Shareholder Nominated Non-Executive Director nominated by Aberdeen Group plc ('Aberdeen'), will cease to be on the Board with effect from 12 October 2026.

 

Following Aberdeen's announcement on 8 October 2026 regarding the sale of 52,000,000 ordinary shares in Standard Life, Aberdeen's shareholding has reduced to approximately 5.3%. Under the terms of its arrangements with Standard Life, Aberdeen no longer satisfies the ownership threshold required to nominate a director to the Board.

 

This announcement is made pursuant to UKLR 6.4.6 of the UK Listing Rules.

 

Enquiries:

Media

Shellie Wells, Corporate Communications  Director, Standard Life plc

+44 (0) 204 559 3031

Investors

Joanne Roberts, Chief Strategy and Investor Relations Officer, Standard Life plc

+44 (0) 204 559 4673

Tom Blackwell, Managing Director, FTI

+44 (0) 7747 133 919


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings